Source:http://linkedlifedata.com/resource/pubmed/id/10910431
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2000-9-8
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0931-0509
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1118-9
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:10910431-Anticholesteremic Agents,
pubmed-meshheading:10910431-Cardiovascular Diseases,
pubmed-meshheading:10910431-Cholesterol,
pubmed-meshheading:10910431-Coronary Disease,
pubmed-meshheading:10910431-Humans,
pubmed-meshheading:10910431-Kidney Failure, Chronic,
pubmed-meshheading:10910431-Risk Factors
|
pubmed:year |
2000
|
pubmed:articleTitle |
Should we reduce blood cholesterol to prevent cardiovascular disease among patients with chronic renal failure?
|
pubmed:publicationType |
Editorial
|